We are live on ! Find out more
IMUX icon

Immunic

54 hedge funds and large institutions have $54.5M invested in Immunic in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $423K | Put options by funds: $166K

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

4% more funds holding

Funds holding: 5254 (+2)

37% less capital invested

Capital invested by funds: $86.7M → $54.5M (-$32.2M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
10
Increased
21
Reduced
11
Closed
8
Calls
$423K
Puts
$166K
Net Calls
+$257K
Net Calls Change
-$865K

IMUX Hedge Fund Activity: Q2 2016 in Review

54 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2016, worth a combined $54.5M — down 37% from $86.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IMUX positions and 8 closed out — a net gain of 2 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $565K. The largest seller was Fidelity Investments, cutting an estimated $6.01M.

  • 54 institutional investors held Immunic (IMUX) as of Q2 2016, up from 52 in Q1 2016.
  • Funds reported $54.5M of Immunic stock for Q2 2016, down 37% quarter-over-quarter.
  • 10 funds opened new Immunic positions in Q2 2016 and 8 closed out, a net change of +2 holders.
  • The largest Immunic buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $565K added.
  • The largest Immunic seller in Q2 2016 was Fidelity Investments, an estimated $6.01M sold.

Based on aggregated 13F filings for Q2 2016.